Gene Therapy for Hemophilia
Gene Therapy for Hemophilia
✓

Shared Decision-Making

00:27:44
Podcasts
RSS
Link

SOBRE ESTE EPISÓDIO

Shared Decision-Making

Over the last several years, gene therapy for hemophilia B has become a reality. Some received it through clinical trials, and others received it after marketing authorizations and reimbursement approvals in their countries. Each of them had a difficult, life-changing decision to make. They needed to fully understand the potential benefits and risks, and the physicians responsible for their treatment needed to be assured that they were providing fully informed consent to the therapy. This process is called shared decision-making. In this episode of our second podcast series, GENE THERAPY FOR HEMOPHILIA – FROM DREAM TO REALITY, four people, two physicians and two people with hemophilia, were invited to share their insight on this topic.

Host: Sarah Ford, CEO, Canadian Hemophilia Society

Guest Speakers: Dr Pratima Chowdary, U.K.; Dr Davide Matino, Canada; Brian O'Mahony, Ireland; David Page, Canada

This series is a creation of The Canadian Hemophilia Society - to find out more go to www.hemophilia.ca/gene-therapy

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Medicina
Medicina
Saúde e fitness
Medicina Alternativa
Inglês
Estados Unidos da América
UseAPIpara buscar este episódio emJSON

NESTE EPISÓDIO

Editar estas etiquetas

TRANSCRIÇÃO 🔗

Are you the producer of this podcast? Add a podcast transcript
Need Audio-to-Text? Transcribe with Listen411 in Just 60 Seconds

PESQUISAR EPISÓDIOS PASSADOS

Pesquisar episódios anteriores de Gene Therapy for Hemophilia.
Incorpore esta barra de pesquisa ao seu site

OUTROS EPISÓDIOS NESTE PODCAST

DEBATE: If gene therapy for hemophilia A were available in Canada tomorrow, Would you want to receive it?

DEBATE: If gene therapy for hemophilia A were available in Canada tomorrow, Would you want to receive it?

In this podcast, Cleaven Pagani, Rick Waines, Paul Wilton and Emil Wijnker, all with severe hemophilia A and also members of the Canadian Hemophilia Society Blood Safety and Supply Committee, are asked to debate the question: “If gene therapy for hemophilia A were available in Canada tomorrow,…
00:16:32
PARTILHAR
GUARDAR
How Might Gene Therapy Be Funded In Canada?

How Might Gene Therapy Be Funded In Canada?

Gene therapy—a high-cost, one-time, potentially life-changing treatment—presents unique challenges for governments that make decisions on funding innovative treatments. Dr. Durhane Wong-Rieger presents creative ideas on new ways to think about how gene therapy for hemophilia A and B could be funded…
00:20:05
PARTILHAR
GUARDAR
What Is The Shared Decision-Making Process In Hemophilia Gene Therapy?

What Is The Shared Decision-Making Process In Hemophilia Gene Therapy?

In this podcast, Dr. Jerry Teitel describes the process of shared decision-making prior to gene therapy in hemophilia A and hemophilia B, and how the nature of gene therapy itself makes shared decision-making so important. Dr. Teitel is a Professor of Medicine at the University of Toronto, and Medi…
00:14:40
PARTILHAR
GUARDAR
What Other Approaches To Hemophilia Gene Therapies Are Down The Road?

What Other Approaches To Hemophilia Gene Therapies Are Down The Road?

The first generation of gene therapy for hemophilia, called gene insertion or gene addition, is now a reality, but it is not for everyone. Dr. Glenn Pierce explores other approaches to gene therapy in the research pipeline that in the future may be more efficacious for a longer time for more people…
00:20:57
PARTILHAR
GUARDAR
How Might Gene Therapy Be Delivered In Canada?

How Might Gene Therapy Be Delivered In Canada?

In this podcast, Dr. Jerry Teitel explores how gene therapy for hemophilia A and hemophilia B might be delivered to patients across Canada in an equitable way, even though the administration will occur in only some sites. He describes the follow-up that is required in the critical months following …
00:12:14
PARTILHAR
GUARDAR
Aviso: O podcast e a arte incorporada nesta página são de Canadian Hemophilia Society, que é propriedade de seu proprietário e não é afiliado ou endossado por Listen Notes, Inc.
PROMOTED
The best Podcast API to search all podcasts and episodes. Trusted by 15,200+ companies and developers.
The best Podcast API to search all podcasts and episodes. Trusted by 15,200+ companies and developers.
PodcastAPI.com

RECOMENDAÇÕES
Use a API para ir buscar este episódio